U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

1997
189
Substance Class Protein
Created
by admin
on Mon Mar 31 20:46:02 GMT 2025
Edited
by admin
on Mon Mar 31 20:46:02 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
CUJ2MVI71Y
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
DACLIZUMAB
DASH   EMA EPAR   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
RO 24-7375
Preferred Name English
DACLIZUMAB [USAN]
Common Name English
Daclizumab [WHO-DD]
Common Name English
DACLIZUMAB [VANDF]
Common Name English
DACLIZUMAB [MART.]
Common Name English
daclizumab [INN]
Common Name English
RO-24-7375
Code English
DACLIZUMAB [PURPLE BOOK CDER]
Common Name English
DACLIXIMAB
Common Name English
DACLIZUMAB [EMA EPAR]
Common Name English
DACLIZUMAB [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C574
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
NDF-RT N0000175621
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
WHO-ATC L04AC01
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
LIVERTOX NBK548018
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
NDF-RT N0000175622
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
NDF-RT N0000175621
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
WHO-VATC QL04AC01
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
EMA ASSESSMENT REPORTS ZENAPAX (WITHDRAWN: GRAFT REJECTION)
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
FDA ORPHAN DRUG 67692
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
EMA ASSESSMENT REPORTS ZENAPAX (WITHDRAWN: KIDNEY TRANSPLANTATION)
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
NDF-RT N0000010279
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
FDA ORPHAN DRUG 67792
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
Code System Code Type Description
RXCUI
190353
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY RxNorm
MERCK INDEX
m4066
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY Merck Index
ChEMBL
CHEMBL1201605
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
NCI_THESAURUS
C1569
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
DRUG BANK
DB00111
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
FDA UNII
CUJ2MVI71Y
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
USAN
FF-43 2
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
LACTMED
Daclizumab
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
WIKIPEDIA
DACLIZUMAB
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
SMS_ID
100000085411
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
EVMPD
SUB06885MIG
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
CAS
152923-56-3
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
IUPHAR
6880
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
INN
7164
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
MESH
C096001
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
DRUG CENTRAL
4953
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
ChEMBL
CHEMBL2108279
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
From To
1_22 1_96
1_143 1_199
1_219 3_213
1_225 2_225
1_228 2_228
1_260 1_320
1_366 1_424
2_22 2_96
2_143 2_199
2_219 4_213
2_260 2_320
2_366 2_424
3_23 3_87
3_133 3_193
4_23 4_87
4_133 4_193
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_296
N 2_296
Related Record Type Details
DACLIZUMAB BETA
SUB_CONCEPT->SUBSTANCE
HIGH AFFINITY IMMUNOGLOBULIN GAMMA FC RECEPTOR I
TARGET -> AGONIST
INTERLEUKIN-2 RECEPTOR SUBUNIT ALPHA
TARGET -> INHIBITOR
Related Record Type Details
DACLIZUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:SEQUENCE CHEMICAL
Biological Half-life PHARMACOKINETIC
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966